Low-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose ...

Ozempic (semaglutide) is a powerful and versatile drug, offering dual benefits: controlling blood sugar in type 2 diabetes, and facilitating weight loss as a secondary effect. While its primary ...

I don’t feel like I’m dragging anymore.” So far, he has experienced no side effects and plans to continue microdosing as long ...

Eli Lilly reduced Zepbound vial prices for self-paying patients via LillyDirect, aiming to lower obesity treatment costs and ...

Eli Lilly ( LLY) is cutting prices for starting doses of Zepbound single-dose vials on its LillyDirect direct-to-consumer platform.

WHO issues 1st guideline on GLP-1s recommending long-term use with behavioral therapy and notes pricing changes from major manufacturers.

Pancreatitis, vision loss ... the risks of drugs such as Ozempic can sound scary. But what does the evidence show?

Eli Lilly’s stock has recently seen its consensus analyst price target rise from $1,003 to $1,024. This change reflects ...

Her teeth are actually aligned perfectly right now,” one “RHONJ” star told The Post about her daughter. “I definitely have seen a change.” ...